DOI: 10.1038/nature02006 [Google Scholar] Kuo CY, Tsou SH, Kornelius E, Chan KC, Chang KW, Li JC, et al
For example, a patient might use phentermine to kickstart their weight loss, then switch to a GLP-1 medication for long-term maintenance
Anderson JM, Van Itallie CM (1995) Tight junctions and the molecular basis for regulation of paracellular permeability
Aratrma iin snr ortaya kar: birincisi, insanda uygulama olmakszn tutarl biimde aratrma maddesi olarak erevelemek
Either the obese individuals have low numbers of dopamine receptors to begin with or their bodies are trying to compensate for having chronically high dopamine levels, which are triggered by chronic overeating
The observed lack of a significant accumulation of PHN in brain following the intraventricular administration of (+)-amphetamine and the formation of appreciable amounts of PHN from (+)-POH in brain tissue in vivo supports the view that the aromatic hydroxylation of amphetamine following its systemic administration occurs predominantly in the periphery, and that POH is then transported through the blood-brain barrier, taken up by noradrenergic neurones in brain where (+)-POH is converted in the storage vesicles by dopamine -hydroxylase to PHN
)
